Merck Reports a 2% Dip in Q1 Sales to $15.5 Billion Amidst Strong Earnings Growth
Merck & Co., Inc. reports a 2% decrease in Q1 sales to $15.5 billion for fiscal 2025, alongside a 7% rise in net income and EPS. CEO Robert M. Davis highlights progress in medicine...